Search

Your search keyword '"Huo, D"' showing total 1,367 results
Start Over Author "Huo, D"
1,367 results on '"Huo, D"'

1. Nosocomial Infections After Pediatric Congenital Heart Disease Surgery: Data from National Center for Cardiovascular Diseases in China

Author

Wang X, Li S, Huo D, Zhu Z, Wang W, He H, Zhang Q, and Li J

Subjects
nosocomial infections, pediatric cardiac surgery, multidrug-resistant organism, surgical outcomes, Infectious and parasitic diseases, RC109-216
Abstract

Xiaofeng Wang,1,2,* Shuo Li,3,* Da Huo,4,* Zhiyuan Zhu,1,2,* Wenlong Wang,1,2 Hongxia He,1,2 Qian Zhang,1,2 Jiantao Li,2,5 Xu Wang1,2 1Department of Pediatric Intensive Care Unit, National Center for Cardiovascular Disease and Fuwai Hospital, Beijing, People’s Republic of China; 2School of Clinical Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People’s Republic of China; 3Department of Infection Control, Peking University First Hospital, Beijing, People’s Republic of China; 4Institute for Infectious Disease and Endemic Disease Control, Beijing Center for Disease Prevention and Control, Beijing, People’s Republic of China; 5Department of Infection Control, National Center for Cardiovascular Disease and Fuwai Hospital, Beijing, People’s Republic of China*These authors contributed equally to this workCorrespondence: Xu Wang, Department of Pediatric Intensive Care Unit, National Center for Cardiovascular Disease and Fuwai Hospital, No. 167 North Lishi Road, Xicheng District, Beijing, 100037, People’s Republic of China, Email fwpicu@163.comPurpose: Infection prevention and control (IPC) has a significant impact on the prognosis after pediatric cardiac surgery. This study aimed to provide surveillance data on the incidence and density of various infections during the COVID-19 epidemic and explore the influence of multi-drug resistant organisms (MDRO) on in-hospital prognosis after congenital heart disease surgery.Methods: This single-center retrospective study included pediatric patients who underwent cardiac surgery between 2021 and 2022. The results of the postoperative bacterial and fungal cultures and antimicrobial stewardship were collected. The demographic characteristics (age and weight), operation-related parameters (RACHS-1 grade, duration of cardiopulmonary bypass, and aortic cross clamp), and surgical outcomes (extracorporeal membrane oxygenation, delayed sternal closure, mortality, duration of mechanical ventilation, length of intensive care unit stay and hospital stay, and hospitalization costs) of MDRO and non-MDRO patients were compared.Results: A total of 4776 patients were included. There were 101 infectious culture results after the operation, with a nosocomial infection rate of 2.1%. There were 40 MDRO specimens from 36 patients, 50 non-MDRO specimens from 30 patients, and 11 fungal specimens from 10 patients. The incidence of pneumonia was 1.5%, with a ventilator-associated pneumonia incidence density of 7.2/1000 patient-days. The incidence of sepsis was 0.4%, with a catheter-related bloodstream infection incidence density of 0.24/ 1000 patient-days. The incidence density of catheter-associated tract infection was 0.45/ 1000 patient-days. The incidence of surgical site infection was 0.06%. The culture proportion before commencing antibiotics was 93% and the antibiotic consumption intensity was 30.7 DDD/100 bed-days. The length of intensive care unit stay in MDRO infection patients increased compared with that in non-MDRO infection patients, 30 (18,52) vs 17 (7,62) days, p=0.05).Conclusion: The IPC performance of Fuwai Hospital achieved satisfactory results. MDRO infection can lead to prolonged intensive care unit stay.Plain language summary: Developed countries have advanced infection prevention and control systems and comprehensive postoperative infection monitoring data for congenital heart disease. While developing countries have initiated efforts in infection prevention and control, global attention remains substantial. This study aimed to provide comprehensive infection surveillance data and identify possible implementation for further improvement in the National Center for Cardiovascular Diseases in China (Fuwai Hospital).This was a retrospective single-center study. We included pediatric patients who underwent cardiac surgery at a pediatric surgical center between 2021 and 2022, with an age limit of 14 years. Exclusion criteria included patients undergoing medical therapy, interventional therapy, or surgical therapy in other centers in Fuwai Hospital.This study, for the first time, reports the incidence of comprehensive healthcare-associated infection surveillance and targeted surveillance (encompassing device-associated infection, surgical site infection, and multi-drug resistant organisms) after pediatric cardiac surgery at the National Center for Cardiovascular Diseases in China. In addition, we report the data on antimicrobial stewardship. We compared the surgical outcome and hospitalization costs between patients with multi-drug resistant organism infection and those without multi-drug resistant organism infection and found that multi-drug resistant organism infection can lead to prolonged intensive care unit length of stay.The Fuwai Hospital achieved satisfactory infection prevention and control results. However, because China is a large developing country exhibiting notable variations in medical conditions across its diverse regions, prospective, multicenter, observational studies should be carried out for future research based on existing evidence.Keywords: nosocomial infections, pediatric cardiac surgery, multidrug-resistant organism, surgical outcomes

Published
2024

4. Influence of Red Blood Cell Distribution Width on All-Cause Death in Critical Diabetic Patients with Acute Kidney Injury

Author

Mo M, Huang Z, Huo D, Pan L, Xia N, Liao Y, and Yang Z

Subjects
diabetes, acute kidney injury, all-cause death, red cell distribution width, critical, Specialties of internal medicine, RC581-951
Abstract

Manqiu Mo,1 Zichun Huang,2 Dongmei Huo,3 Ling Pan,3 Ning Xia,1 Yunhua Liao,3,&ast; Zhenhua Yang3,&ast; 1Geriatric Department of Endocrinology, the First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, People’s Republic of China; 2Department of Cardiovascular Thoracic Surgery, the Third Affiliated Hospital of Guangxi Medical University: Nanning Second People’s Hospital, Nanning, 530031, People’s Republic of China; 3Department of Nephrology, the First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, People’s Republic of China&ast;These authors contributed equally to this workCorrespondence: Zhenhua Yang; Yunhua Liao, Department of Nephrology, the First Affiliated Hospital of Guangxi Medical University, No. 6, Shuangyong Road, Nanning, 530021, Guangxi, People’s Republic of China, Email 593456108@qq.com; yunhualiao1962@163.comObjective: To explore the relationship between red blood cell distribution width (RDW) and all-cause death in critical diabetic patients with acute kidney injury (AKI).Methods: The clinical data of critical diabetic patients with AKI in MIMIC-III database were analyzed retrospectively. According to the survival status of 28-day after AKI and levels of RDW, patients were divided into survival and death groups, high RDW (RDW > 15.3%) and low RDW groups (RDW ≤ 15.3%). Kaplan–Meier curves were used to compare the survival rates of diabetic patients with AKI in different RDW and AKI stages, and Cox regression analysis was used to evaluate the risk factors of 28-day all-cause death in critical diabetic patients with AKI.Results: A total of 5200 patients with critical diabetic patients with AKI were included in this study with the male to female ratio of 1.53:1. The mean follow-up time was 24.97 ± 7.14 days, and the 28-day all-cause mortality was 17.9% (931/5200). Age, RDW, blood urea nitrogen, serum creatinine, lactic acid, proportion of AKI stage, sepsis and respiratory failure in the death group were higher than those in the survival group, while mean arterial pressure (MAP) and red blood cell count were lower than those in the survival group. Kaplan–Meier analysis showed that the 28-day survival rate of the high RDW group was significantly lower than that of the low RDW group (log-rank χ2 = 9.970, P = 0.002). Multivariate Cox regression analysis showed that advanced age (HR = 1.042, 95% CI = 1.021– 1.063), decreased MAP (HR = 0.984, 95% CI = 0.969– 0.998), stage 3 AKI (HR = 3.318, 95% CI = 1.598– 6.890) and increased RDW (HR = 1.255, 95% CI = 1.123– 1.403) were independent risk factors of 28-day all-cause death in critical diabetic patients with AKI (P < 0.05).Conclusion: High level of RDW is an important risk factor of all-cause death in critical diabetic patients with AKI, and it may be used as a valuable index to classify the mortality.Keywords: diabetes, acute kidney injury, all-cause death, red cell distribution width, critical

Published
2022

7. Quantification of Exposure to Pm2.5-bound Metals and Cognitive Function in Nigerian Children

Author

Ibigbami, T.B., primary, Ayoola, F., additional, Chartier, R.T., additional, Adekunle, S.T., additional, Adepoju, D., additional, Adebanjo, I., additional, Fatile, S., additional, Abraham, T., additional, Adesina, S., additional, Omoniyi, O., additional, Timilehin, O., additional, Omolola, O., additional, Awwal, A., additional, Olushola, F., additional, Remilekun, A., additional, Bukunmi, A., additional, Ajani, O., additional, Deji-Abiodun, O.A., additional, Adeniyi, Y., additional, Duncan, S., additional, Taiwo, O., additional, Arinola, G.O., additional, Falade, A.G., additional, Ojengbede, O., additional, Giurcanu, M., additional, Huo, D., additional, Dutta, A., additional, and Olopade, C.O., additional

Published
2024
Full Text
View/download PDF

8. Deep Inferior Epigastric Flap Combined Bilateral-Anterolateral Thigh Flap for the Coverage of Both Lower Extremity Soft-Tissue Defect: A Case Report and a Literature Review

Author

Liu X, Huo D, and Wu G

Subjects
anterolateral thigh free flap, deep inferior epigastric artery perforator flap, soft tissue repair, skin repair, Dermatology, RL1-803
Abstract

Xilin Liu,* Da Huo,* Guangzhi Wu Department of Hand Surgery, China-Japan Union Hospital of Jilin University, Changchun, 130033, People’s Republic of China*These authors contributed equally to this workCorrespondence: Guangzhi Wu Tel +86-13944181019Email wuguangzhi@jlu.edu.cnBackground/Purpose: Anterolateral thigh perforator (ALTP) flap and deep inferior epigastric perforator (DIEP) flap have been advantageous over traditional myocutaneous flaps as they preserve the integrity of donor site muscles and minimize the damage and complication to donor site structures. Here, we reported the efficacy of free ALTP and DIEP in the repair of large skin area and soft tissue defects on both lower limbs after trauma.Case Report: A 19-year-old female traffic accident victim presented with multiple open bilateral fractures to the lower extremities with joint dislocation, massive skin and soft tissue defects, and multiple soft tissue contusion. Wounds on both lower extremities were covered with VSD (Vacuum Sealing Drainage). The tibiofibular and ankle joints on both lower limbs were fixed using external fixators. DIEP and ALTP flap were performed at different times.Results: After transfer, the vascular pedicle was anastomosed to the anterior tibial artery, posterior tibial artery, and the accompanying vein. After the operation, the donor site was directly closed and sutured. All flaps survived with a good appearance, leaving only a linear scar at the donor site.Conclusion: This case shows that free ALTP and DIEP flaps are ideal for repairing large skin area and soft tissue defects in bilateral lower limbs after trauma.Keywords: anterolateral thigh perforator flap, deep inferior epigastric perforator flap, soft tissue repair, skin repair

Published
2021

10. Tunable charge carriers and thermoelectricity of single-crystal Ba8Ga16Sn30

Author

Avila, M. A., Huo, D., Sakata, T., Suekuni, K., and Takabatake, T.

Subjects
Condensed Matter - Strongly Correlated Electrons, Condensed Matter - Materials Science
Abstract

We have grown single crystals of the type-VIII intermetallic clathrate Ba8Ga16Sn30 from both Sn and Ga flux, evaluated their compositions through electron microprobe analysis and studied their transport properties through measurements on temperature dependent resistivity, thermopower and Hall coefficient. Crystals grown in Sn flux show n-type carriers and those from Ga flux show p-type carriers, whereas all measured compositions remain very close to the stoichiometric 8:16:30 proportion of Ba:Ga:Sn, expected from charge-balance principles. Our results indicate a very high sensitivity of the charge carrier nature and density with respect to the growth conditions, leading to relevant differences in transport properties which point to the importance of tuning this material for optimal thermoelectric performance., Comment: Revised version accepted in J. Phys.: Cond. Mat

Published
2005
Full Text
View/download PDF

11. Structural, transport, and thermal properties of single crystalline type-VIII clathrate Ba8Ga16Sn30

Author

Huo, D., Sakata, T., Sasakawa, T., Avila, M. A., Tsubota, M., Iga, F., Fukuoka, H., Yamanaka, S., Aoyagi, S., and Takabatake, T.

Subjects
Condensed Matter - Strongly Correlated Electrons, Condensed Matter - Materials Science
Abstract

We report the electrical resistivity, Hall coefficient, thermoelectric power, specific heat, and thermal conductivity on single crystals of the type-VIII clathrate Ba8Ga16Sn30 grown from Sn-flux. Negative S and R_H over a wide temperature range indicate that electrons dominate electrical transport properties. Both rho(T) and S(T) show typical behavior of a heavily doped semiconductor. The absolute value of S increases monotonically to 243 uV/K with increasing temperature up to 550 K. The large S may originate from the low carrier concentration n=3.7x10^19 cm^(-3). Hall mobility u_H shows a maximum of 62 cm^2/Vs around 70 K. The analysis of temperature dependence of u_H suggests a crossover of dominant scattering mechanism from ionized impurity to acoustic phonon scattering with increasing temperature. The existence of local vibration modes of Ba atoms in cages composed of Ga and Sn atoms is evidenced by analysis of experimental data of structural refinement and specific heat, which give an Einstein temperature of 50 K and a Debye temperature of 200 K. This local vibration of Ba atoms should be responsible for the low thermal conductivity (1.1 W/m K at 150 K). The potential of type-VIII clathrate compounds for thermoelectric application is discussed., Comment: 6 pages, 6 figures, submitted to Phys. Rev. B

Published
2004
Full Text
View/download PDF

14. Disclosure of cancer diagnosis in China: the incidence, patients’ situation, and different preferences between patients and their family members and related influence factors

Author

Liu Y, Yang J, Huo D, Fan H, and Gao Y

Subjects
cancer, diagnosis disclosure, China, patient, family member, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
Abstract

Yuxiu Liu,1,2 Jinhong Yang,3 Da Huo,3 Honghua Fan,3 Yufang Gao4 1Post-Doctoral Station of Clinical Medicine, The Affiliated Hospital of Qingdao University, Qingdao, China; 2Department of Community Nursing, School of Nursing, Weifang Medical University, Weifang, China; 3Department of Oncology, Weifang People’s Hospital, Weifang, China; 4Department of Nursing, The Affiliated Hospital of Qingdao University, Qingdao, China Purpose: The purpose of this study was to investigate the disclosure incidence of cancer diagnosis to patients before chemotherapy, to survey the attitudes of the patients and their families and related influencing factors toward disclosure of cancer diagnosis, and to compare the anxiety and depression levels between the disclosure and non-disclosure patients.Participants and methods: A prospective cohort study was conducted at a tertiary hospital in China. A consecutive series of patients who had been diagnosed with malignancy by pathology and their family member were included in our study from March 2017 to December 2017. Patients’ situation, preferences, and their family members’ preferences were investigated by a self-designed questionnaire following a semi-structured interview. The Chinese version of HADS for anxiety and depression was used to test the patients’ psychological distress. Binary logistic regression was used to analyze the related influencing factors of patients’ disclosure of their diagnosis.Results: A total of 124 pairs of patients and their family members were analyzed. Of the 124 patients, 47 (37.90%) patients knew about their cancer diagnosis and 77 (62.10%) patients did not know about their cancer diagnosis before chemotherapy. There were more patients than family members who wanted the patients to be informed about the diagnosis of terminal illness (91.9% vs 53.2%, P0.05). Conclusion: More than half of the patients did not know their exact diagnosis before chemotherapy in China. Educational level and economic status may be influencing factors for the disclosure of cancer diagnosis. Patients and their family members had different preferences toward diagnosis disclosure. Keywords: cancer, diagnosis disclosure, China, patient, family member

Published
2018

17. Parity and breastfeeding are protective against breast cancer in Nigerian women

Author

Huo, D, Adebamowo, CA, Ogundiran, TO, Akang, EE, Campbell, O, Adenipekun, A, Cummings, S, Fackenthal, J, Ademuyiwa, F, Ahsan, H, and Olopade, OI

Subjects
Breast Cancer, Clinical Research, Cancer, Prevention, Reproductive health and childbirth, Good Health and Well Being, Adult, Breast Feeding, Breast Neoplasms, Female, Humans, Middle Aged, Nigeria, Parity, Pregnancy, Receptors, Estrogen, Risk Factors, Oncology and Carcinogenesis, Public Health and Health Services, Oncology & Carcinogenesis
Abstract

As the relation between reproductive factors and breast cancer risk has not been systematically studied in indigenous women of sub-Saharan Africa, we examined this in a case-control study in Nigeria. In-person interviews were conducted using structured questionnaires to collect detailed reproductive history in 819 breast cancer cases and 569 community controls between 1998 and 2006. Logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CI). Compared with women with menarcheal ageor=17 years was 0.72 (95% CI: 0.54-0.95, P=0.02). Parity was negatively associated with risk (P-trend=0.02) but age at first live birth was not significant (P=0.16). Importantly, breast cancer risk decreased by 7% for every 12 months of breastfeeding (P-trend=0.005). It is worth noting that the distribution of reproductive risk factors changed significantly from early to late birth cohorts in the direction of increasing breast cancer incidence. Our findings also highlight the heterogeneity of breast cancer aetiology across populations, and indicate the need for further studies among indigenous sub-Saharan women.

Published
2008

18. The antiferromagnetic ordering and metamagnetic transition induced magnetodielectric effect in Dy2Cu2O5.

Author

Huang, S., Jin, H., Wan, K. Q., Wang, H. O., Su, K. P., Yang, D. X., Yang, L., and Huo, D. X.

Subjects
METAMAGNETISM, DIELECTRIC relaxation, MAGNETIC flux density, PERMITTIVITY, MAGNETIC properties, FERROELECTRICITY
Abstract

Ferroelectricity and magnetism seldom coexist due to mutual exclusiveness. Recent attempts have been made to achieve the coexistence of ferroelectricity and magnetism in polar magnets. In this paper, we investigated the magnetic properties, dielectric relaxation, and magnetodielectric (MD) effect of polar Dy2Cu2O5 ceramic. At the antiferromagnetic ordering temperature, the dielectric constant (ɛ) curves exhibit a spontaneous change in slope, indicating strongly coupled charge and spin degrees of freedom. With increase in the magnetic field intensity, the simultaneous suppression of the dielectric anomaly and the antiferromagnetic transformation demonstrates the existence of the MD effect. It is important to note that ɛ varies nonmonotonically with the magnetic field. Below the magnetic ordering temperature, ɛ increases continuously before the metamagnetic transition and then decreases after that. The results are discussed in terms of the magnetic field-induced change of spin configuration and spin–phonon coupling. Moreover, two dielectric relaxation-related steps are observed, which are correlated with the electrons hopping within and among the zigzag chains of Cu2+, respectively. This work helps understand the dielectric behavior and the MD effect in materials with complicated spin structures. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

19. Effects of interfacial surfactant contamination on bubble gas transfer

Author

Rosso, D, Huo, D L, and Stenstrom, M K

Subjects
adsorption, aeration, bubble, gas-liquid interface, mass transfer, surfactant
Abstract

Surface active agents depress gas transfer at gas-liquid interfaces. They are present as measurable trace contaminants at all environmental and at most industrial interfaces. An experimental apparatus to concurrently measure dynamic surface tension and mass transfer was constructed and tested for single-bubble and multi-bubble experiments. In this work, the parameters describing time-dependent bubble surface contamination were characterized. The application of a Ward-Tordai transient model and of a Langmuir saturation model showed that for fine-bubbles in low molecular weight surfactant solutions the interfacial surfactant accumulation equilibrates before bubble detachment. This is reflected in the bubbles behaving as solid-spheres, which is shown in our dimensionless results. For a given contamination, interfaces with higher renewal rates have higher mass transfer. At higher renewal rates, the variation due to different contamination is smaller than the variation at lower renewal rates, concluding that higher interfacial flow regimes can offset contamination. Our experimental evidence shows a gas transfer reduction of 30-70% of pure water values in surfactant solutions, which confirms full-scale field measurements. Results are consistent with expectations and correct previous Frossling-like dimensionless correlations for pure water systems. Our results offer a tool for mass transfer prediction from flow regime and surfactant properties. (c) 2006 Elsevier Ltd. All rights reserved.

Published
2006

23. Robustness evaluation of control algorithms for a long-stroke fast tool servo

Author

Gong, Z, Huo, D, Niu, Z, Chen, W, and Cheng, K

Subjects
fast tool servo, control algorithm, Strategy and Management, tracking error, robustness, Management Science and Operations Research, microstructured surface, Industrial and Manufacturing Engineering
Abstract

Copyright © 2022 The Authors. Fast tool servo (FTS) is an effective freeform surface machining technology in precision machining. The robustness of the FTS control algorithm is an important factor influencing the quality of machining. In this paper, an advanced PID control algorithm and a hybrid control algorithm are tested on a Lorentz force FTS. A mathematical simulation model is built according to the system characteristics. The model is verified by the system identification model and used for the simulation of the system's motion under disturbance. Simulation results show that the advanced PID control results in more significant differences in tracking error, amplitude error, and phase errors than the hybrid control. Four machining experiments are designed and conducted. The motion profile results from simulations and experiments show that the hybrid control (1.5% tracking error). In addition, the hybrid control exhibits rapid response speed. From the 3D profile of the machined microstructured surface, the hybrid control helps to achieve better form accuracy in the workpiece than the advanced PID control.

Published
2022

24. Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry

Author

Mueller, SH, Lai, AG, Valkovskaya, M, Michailidou, K, Bolla, MK, Wang, Q, Dennis, J, Lush, M, Abu-Ful, Z, Ahearn, TU, Andrulis, IL, Anton-Culver, H, Antonenkova, NN, Arndt, V, Aronson, KJ, Augustinsson, A, Baert, T, Freeman, LEB, Beckmann, MW, Behrens, S, Benitez, J, Bermisheva, M, Blomqvist, C, Bogdanova, N, Bojesen, SE, Bonanni, B, Brenner, H, Brucker, SY, Buys, SS, Castelao, JE, Chan, TL, Chang-Claude, J, Chanock, SJ, Choi, J-Y, Chung, WK, Colonna, S, Cornelissen, S, Couch, FJ, Czene, K, Daly, MB, Devilee, P, Dork, T, Dossus, L, Dwek, M, Eccles, DM, Ekici, AB, Eliassen, AH, Engel, C, Evans, DG, Fasching, PA, Fletcher, O, Flyger, H, Gago-Dominguez, M, Gao, Y-T, Garcia-Closas, M, Garcia-Saenz, JA, Genkinger, J, Gentry-Maharaj, A, Grassmann, F, Guenel, P, Gundert, M, Haeberle, L, Hahnen, E, Haiman, CA, Hakansson, N, Hall, P, Harkness, EF, Harrington, PA, Hartikainen, JM, Hartman, M, Hein, A, Ho, W-K, Hooning, MJ, Hoppe, R, Hopper, JL, Houlston, RS, Howell, A, Hunter, DJ, Huo, D, Investigators, A, Ito, H, Iwasaki, M, Jakubowska, A, Janni, W, John, EM, Jones, ME, Jung, A, Kaaks, R, Kang, D, Khusnutdinova, EK, Kim, S-W, Kitahara, CM, Koutros, S, Kraft, P, Kristensen, VN, Kubelka-Sabit, K, Kurian, AW, Kwong, A, Lacey, J, Lambrechts, D, Le Marchand, L, Li, J, Linet, M, Lo, W-Y, Long, J, Lophatananon, A, Mannermaa, A, Manoochehri, M, Margolin, S, Matsuo, K, Mavroudis, D, Menon, U, Muir, K, Murphy, RA, Nevanlinna, H, Newman, WG, Niederacher, D, O'Brien, KM, Obi, N, Offit, K, Olopade, O, Olshan, AF, Olsson, H, Park, SK, Patel, A, Perou, CM, Peto, J, Pharoah, PDP, Plaseska-Karanfilska, D, Presneau, N, Rack, B, Radice, P, Ramachandran, D, Rashid, MU, Rennert, G, Romero, A, Ruddy, KJ, Ruebner, M, Saloustros, E, Sandler, DP, Sawyer, EJ, Schmidt, MK, Schmutzler, RK, Schneider, MO, Scott, C, Shah, M, Sharma, P, Shen, C-Y, Shu, X-O, Simard, J, Surowy, H, Tamimi, RM, Tapper, WJ, Taylor, JA, Teo, SH, Teras, LR, Toland, AE, Tollenaar, RAEM, Torres, D, Torres-Mejia, G, Troester, MA, Truong, T, Vachon, CM, Vijai, J, Weinberg, CR, Wendt, C, Winqvist, R, Wolk, A, Wu, AH, Yamaji, T, Yang, XR, Yu, J-C, Zheng, W, Ziogas, A, Ziv, E, Dunning, AM, Easton, DF, Hemingway, H, Hamann, U, Kuchenbaecker, KB, Mueller, SH, Lai, AG, Valkovskaya, M, Michailidou, K, Bolla, MK, Wang, Q, Dennis, J, Lush, M, Abu-Ful, Z, Ahearn, TU, Andrulis, IL, Anton-Culver, H, Antonenkova, NN, Arndt, V, Aronson, KJ, Augustinsson, A, Baert, T, Freeman, LEB, Beckmann, MW, Behrens, S, Benitez, J, Bermisheva, M, Blomqvist, C, Bogdanova, N, Bojesen, SE, Bonanni, B, Brenner, H, Brucker, SY, Buys, SS, Castelao, JE, Chan, TL, Chang-Claude, J, Chanock, SJ, Choi, J-Y, Chung, WK, Colonna, S, Cornelissen, S, Couch, FJ, Czene, K, Daly, MB, Devilee, P, Dork, T, Dossus, L, Dwek, M, Eccles, DM, Ekici, AB, Eliassen, AH, Engel, C, Evans, DG, Fasching, PA, Fletcher, O, Flyger, H, Gago-Dominguez, M, Gao, Y-T, Garcia-Closas, M, Garcia-Saenz, JA, Genkinger, J, Gentry-Maharaj, A, Grassmann, F, Guenel, P, Gundert, M, Haeberle, L, Hahnen, E, Haiman, CA, Hakansson, N, Hall, P, Harkness, EF, Harrington, PA, Hartikainen, JM, Hartman, M, Hein, A, Ho, W-K, Hooning, MJ, Hoppe, R, Hopper, JL, Houlston, RS, Howell, A, Hunter, DJ, Huo, D, Investigators, A, Ito, H, Iwasaki, M, Jakubowska, A, Janni, W, John, EM, Jones, ME, Jung, A, Kaaks, R, Kang, D, Khusnutdinova, EK, Kim, S-W, Kitahara, CM, Koutros, S, Kraft, P, Kristensen, VN, Kubelka-Sabit, K, Kurian, AW, Kwong, A, Lacey, J, Lambrechts, D, Le Marchand, L, Li, J, Linet, M, Lo, W-Y, Long, J, Lophatananon, A, Mannermaa, A, Manoochehri, M, Margolin, S, Matsuo, K, Mavroudis, D, Menon, U, Muir, K, Murphy, RA, Nevanlinna, H, Newman, WG, Niederacher, D, O'Brien, KM, Obi, N, Offit, K, Olopade, O, Olshan, AF, Olsson, H, Park, SK, Patel, A, Perou, CM, Peto, J, Pharoah, PDP, Plaseska-Karanfilska, D, Presneau, N, Rack, B, Radice, P, Ramachandran, D, Rashid, MU, Rennert, G, Romero, A, Ruddy, KJ, Ruebner, M, Saloustros, E, Sandler, DP, Sawyer, EJ, Schmidt, MK, Schmutzler, RK, Schneider, MO, Scott, C, Shah, M, Sharma, P, Shen, C-Y, Shu, X-O, Simard, J, Surowy, H, Tamimi, RM, Tapper, WJ, Taylor, JA, Teo, SH, Teras, LR, Toland, AE, Tollenaar, RAEM, Torres, D, Torres-Mejia, G, Troester, MA, Truong, T, Vachon, CM, Vijai, J, Weinberg, CR, Wendt, C, Winqvist, R, Wolk, A, Wu, AH, Yamaji, T, Yang, XR, Yu, J-C, Zheng, W, Ziogas, A, Ziv, E, Dunning, AM, Easton, DF, Hemingway, H, Hamann, U, and Kuchenbaecker, KB

Abstract

BACKGROUND: Low-frequency variants play an important role in breast cancer (BC) susceptibility. Gene-based methods can increase power by combining multiple variants in the same gene and help identify target genes. METHODS: We evaluated the potential of gene-based aggregation in the Breast Cancer Association Consortium cohorts including 83,471 cases and 59,199 controls. Low-frequency variants were aggregated for individual genes' coding and regulatory regions. Association results in European ancestry samples were compared to single-marker association results in the same cohort. Gene-based associations were also combined in meta-analysis across individuals with European, Asian, African, and Latin American and Hispanic ancestry. RESULTS: In European ancestry samples, 14 genes were significantly associated (q < 0.05) with BC. Of those, two genes, FMNL3 (P = 6.11 × 10-6) and AC058822.1 (P = 1.47 × 10-4), represent new associations. High FMNL3 expression has previously been linked to poor prognosis in several other cancers. Meta-analysis of samples with diverse ancestry discovered further associations including established candidate genes ESR1 and CBLB. Furthermore, literature review and database query found further support for a biologically plausible link with cancer for genes CBLB, FMNL3, FGFR2, LSP1, MAP3K1, and SRGAP2C. CONCLUSIONS: Using extended gene-based aggregation tests including coding and regulatory variation, we report identification of plausible target genes for previously identified single-marker associations with BC as well as the discovery of novel genes implicated in BC development. Including multi ancestral cohorts in this study enabled the identification of otherwise missed disease associations as ESR1 (P = 1.31 × 10-5), demonstrating the importance of diversifying study cohorts.

Published
2023

31. α-MSH-PE38KDEL Kills Melanoma Cells via Modulating Erk1/2/MITF/TYR Signaling in an MC1R-Dependent Manner

Author

Liu X, Li H, Cong X, Huo D, Cong L, and Wu G

Subjects
integumentary system, mc1r, viability, melanoma, apoptosis, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, lcsh:RC254-282, α-msh-pe38kdel, erk1/2/mitf/tyr
Abstract

Xilin Liu,1,* Hong Li,2,* Xianling Cong,3 Da Huo,1 Lele Cong,4 Guangzhi Wu1 1Department of Hand Surgery, China Japan Union Hospital of Jilin University, Changchun City, Jilin Province 130033, People’s Republic of China; 2Emergency Medical Department, China Japan Union Hospital of Jilin University, Changchun City, Jilin Province 130033, People’s Republic of China; 3Tissue Bank, China Japan Union Hospital of Jilin University, Changchun City, Jilin Province 130033, People’s Republic of China; 4Department of Dermatology, China Japan Union Hospital of Jilin University, Changchun City, Jilin Province 130033, People’s Republic of China*These authors contributed equally to this workCorrespondence: Guangzhi WuDepartment of Hand Surgery, China Japan Union Hospital of Jilin University, Changchun City, Jilin Province 130033, People’s Republic of ChinaTel +86-13944181019Email wuguangzhi@jlu.edu.cnBackground/Objective: The immunotoxin α-MSH-PE38KDEL consisting of α-MSH and PE38KDEL showed high cytotoxicity on MSH receptor-positive melanoma cells, suggesting that α-MSH-PE38KDEL might be a potent drug for the treatment of melanoma. Herein, we explored whether the Erk1/2/MITF/TYR signaling, a verified target of α-MSH/MC1R, was involved in α-MSH-PE38KDEL-mediated cytotoxicity.Methods: Human melanoma cell line A375, mouse melanoma cell line B16-F10, human breast cancer cell line MDA-MB-231 and human primary epidermal melanocytes (HEMa) with different expression levels of MC1R were used in this study. Cell apoptosis and viability were determined by using flow cytometry and MTT assays. Protein expressions were tested by Western blotting.Results: The expression levels of MC1R in A375 and B16-F10 cells were significantly higher than that of MDA-MB-231 and HEMa. α-MSH-PE38KDEL treatment induced a significant inhibition in cell viability in A375 and B16-F10 cells, while showed no obvious influence in the viability of MDA-MB-231 and HEMa cells. However, knockdown of MC1R abolished α-MSH-PE38KDEL role in promoting cell apoptosis in A375 and B16-F10 cells, and upregulation of MC1R endowed α-MSH-PE38KDEL function to promote cell apoptosis in MDA-MB-231 and HEMa cells. Additionally, α-MSH-PE38KDEL treatment increased the phosphorylation levels of Erk1/2 and MITF (S73), and decreased MITF and TYR expressions in an MC1R-dependent manner. All of the treatments, including inhibition of Erk1/2 with PD98059, MC1R downregulation and MITF overexpression weakened the anti-tumor role of α-MSH-PE38KDEL in melanoma.Conclusion: Collectively, this study indicates that α-MSH-PE38KDEL promotes melanoma cell apoptosis via modulating Erk1/2/MITF/TYR signaling in an MC1R-dependent manner.Keywords: MC1R, melanoma, α-MSH-PE38KDEL, apoptosis, viability, Erk1/2/MITF/TYR

Published
2020

32. Investigation on an integrated approach to modelling and analysis of multi-axis aerostatic bearing stages for high precision performance

Author

Gou, N, Cheng, K, and Huo, D

Subjects
integrated modelling and analysis, cross-coupling control, high precision mechatronics, aerostatic bearing, high precision multi-axis stages
Abstract

Multi-axis aerostatic bearing stages are one of key enabling element units for precision and ultra-precision machines. These stages are essentially important for high precision positioning of the tool and/or workpiece and their dynamic and static actuation, while their higher and more robust dynamic performance is increasingly demanded. In this paper, an integrated modelling and analysis approach is presented for the multi-axis aerostatic bearing stages system. The approach is focused on addressing two folds of challenges, i.e. the integrated analysis of mechanical design, electric drive actuation through the advanced cross-coupling-controller with variable gains for a direct drive aerostatic bearing linear stages as a complete high precision mechatronic system, and the simultaneous tuning and further analysis of the multi-axis aerostatic bearing stage system through PID control algorithms. It thus aims to achieve the higher positioning accuracy, response time and stability of the stage motions, especially during the high-speed multi-axis synchronized actuations in a precision engineering application. The modelling and analysis are implemented in MATLAB/Simulink environment and further supported by advanced control functions particularly for coupling, tuning and dynamic performance analysis. The paper is concluded with a further discussion on the potential and application of the approach for high precision multi-axis stages.

Published
2022

43. Development and external validation of a breast cancer absolute risk prediction model in Chinese population.

Author

Han, Y, Lv, J, Yu, C, Guo, Y, Bian, Z, Hu, Y, Yang, L, Chen, Y, Du, H, Zhao, F, Wen, W, Shu, X-O, Xiang, Y, Gao, Y-T, Zheng, W, Guo, H, Liang, P, Chen, J, Chen, Z, Huo, D, Li, L, China Kadoorie Biobank Collaborative Group, Han, Y, Lv, J, Yu, C, Guo, Y, Bian, Z, Hu, Y, Yang, L, Chen, Y, Du, H, Zhao, F, Wen, W, Shu, X-O, Xiang, Y, Gao, Y-T, Zheng, W, Guo, H, Liang, P, Chen, J, Chen, Z, Huo, D, Li, L, and China Kadoorie Biobank Collaborative Group

Abstract

BACKGROUNDS: In contrast to developed countries, breast cancer in China is characterized by a rapidly escalating incidence rate in the past two decades, lower survival rate, and vast geographic variation. However, there is no validated risk prediction model in China to aid early detection yet. METHODS: A large nationwide prospective cohort, China Kadoorie Biobank (CKB), was used to evaluate relative and attributable risks of invasive breast cancer. A total of 300,824 women free of any prior cancer were recruited during 2004-2008 and followed up to Dec 31, 2016. Cox models were used to identify breast cancer risk factors and build a relative risk model. Absolute risks were calculated by incorporating national age- and residence-specific breast cancer incidence and non-breast cancer mortality rates. We used an independent large prospective cohort, Shanghai Women's Health Study (SWHS), with 73,203 women to externally validate the calibration and discriminating accuracy. RESULTS: During a median of 10.2 years of follow-up in the CKB, 2287 cases were observed. The final model included age, residence area, education, BMI, height, family history of overall cancer, parity, and age at menarche. The model was well-calibrated in both the CKB and the SWHS, yielding expected/observed (E/O) ratios of 1.01 (95% confidence interval (CI), 0.94-1.09) and 0.94 (95% CI, 0.89-0.99), respectively. After eliminating the effect of age and residence, the model maintained moderate but comparable discriminating accuracy compared with those of some previous externally validated models. The adjusted areas under the receiver operating curve (AUC) were 0.634 (95% CI, 0.608-0.661) and 0.585 (95% CI, 0.564-0.605) in the CKB and the SWHS, respectively. CONCLUSIONS: Based only on non-laboratory predictors, our model has a good calibration and moderate discriminating capacity. The model may serve as a useful tool to raise individuals' awareness and aid risk-stratified screening and prevention strategi

Published
2021

48. Two truncating variants in FANCC and breast cancer risk.

Author

Gaudet M.M., Kaaks R., Kang D., Kwong A., Lambrechts D., Marchand L.L., Li J., Lindstrom S., Linet M., Lo W.-Y., Long J., Lophatananon A., Lubinski J., Manoochehri M., Manoukian S., Margolin S., Martinez E., Matsuo K., Mavroudis D., Meindl A., Menon U., Milne R.L., Mohd Taib N.A., Muir K., Mulligan A.M., Neuhausen S.L., Nevanlinna H., Neven P., Newman W.G., Offit K., Olopade O.I., Olshan A.F., Olson J.E., Olsson H., Park S.K., Park-Simon T.-W., Peto J., Plaseska-Karanfilska D., Pohl-Rescigno E., Presneau N., Rack B., Radice P., Rashid M.U., Rennert G., Rennert H.S., Romero A., Ruebner M., Saloustros E., Schmidt M.K., Schmutzler R.K., Schneider M.O., Schoemaker M.J., Scott C., Shen C.-Y., Shu X.-O., Simard J., Slager S., Smichkoska S., Southey M.C., Spinelli J.J., Stone J., Surowy H., Swerdlow A.J., Tamimi R.M., Tapper W.J., Teo S.H., Terry M.B., Toland A.E., Tollenaar R.A.E.M., Torres D., Torres-Mejia G., Troester M.A., Truong T., Tsugane S., Untch M., Vachon C.M., Ouweland A.M.W.V.D., Veen E.M.V., Vijai J., Wendt C., Wolk A., Yu J.-C., Zheng W., Ziogas A., Ziv E., Dunning A.M., Pharoah P.D.P., Schindler D., Devilee P., Easton D.F., Hopper J.L., Howell T., Huo D., Ito H., Iwasaki M., Jakubowska A., Janni W., John E.M., Dork T., Peterlongo P., Mannermaa A., Bolla M.K., Wang Q., Dennis J., Ahearn T., Andrulis I.L., Anton-Culver H., Arndt V., Aronson K.J., Augustinsson A., Freeman L.E.B., Beckmann M.W., Beeghly-Fadiel A., Behrens S., Bermisheva M., Blomqvist C., Bogdanova N.V., Bojesen S.E., Brauch H., Brenner H., Burwinkel B., Canzian F., Chan T.L., Chang-Claude J., Chanock S.J., Choi J.-Y., Christiansen H., Clarke C.L., Couch F.J., Czene K., Daly M.B., Dos-Santos-Silva I., Dwek M., Eccles D.M., Ekici A.B., Eriksson M., Evans D.G., Fasching P.A., Figueroa J., Flyger H., Fritschi L., Gabrielson M., Gago-Dominguez M., Gao C., Gapstur S.M., Garcia-Closas M., Garcia-Saenz J.A., Jung A., Giles G.G., Goldberg M.S., Goldgar D.E., Guenel P., Haeberle L., Haiman C.A., Hakansson N., Hall P., Hamann U., Hartman M., Hauke J., Hein A., Hillemanns P., Hogervorst F.B.L., Hooning M.J., Kapoor P.M., Khusnutdinova E., Kim S.-W., Kitahara C.M., Koutros S., Kraft P., Kristensen V.N., Gaudet M.M., Kaaks R., Kang D., Kwong A., Lambrechts D., Marchand L.L., Li J., Lindstrom S., Linet M., Lo W.-Y., Long J., Lophatananon A., Lubinski J., Manoochehri M., Manoukian S., Margolin S., Martinez E., Matsuo K., Mavroudis D., Meindl A., Menon U., Milne R.L., Mohd Taib N.A., Muir K., Mulligan A.M., Neuhausen S.L., Nevanlinna H., Neven P., Newman W.G., Offit K., Olopade O.I., Olshan A.F., Olson J.E., Olsson H., Park S.K., Park-Simon T.-W., Peto J., Plaseska-Karanfilska D., Pohl-Rescigno E., Presneau N., Rack B., Radice P., Rashid M.U., Rennert G., Rennert H.S., Romero A., Ruebner M., Saloustros E., Schmidt M.K., Schmutzler R.K., Schneider M.O., Schoemaker M.J., Scott C., Shen C.-Y., Shu X.-O., Simard J., Slager S., Smichkoska S., Southey M.C., Spinelli J.J., Stone J., Surowy H., Swerdlow A.J., Tamimi R.M., Tapper W.J., Teo S.H., Terry M.B., Toland A.E., Tollenaar R.A.E.M., Torres D., Torres-Mejia G., Troester M.A., Truong T., Tsugane S., Untch M., Vachon C.M., Ouweland A.M.W.V.D., Veen E.M.V., Vijai J., Wendt C., Wolk A., Yu J.-C., Zheng W., Ziogas A., Ziv E., Dunning A.M., Pharoah P.D.P., Schindler D., Devilee P., Easton D.F., Hopper J.L., Howell T., Huo D., Ito H., Iwasaki M., Jakubowska A., Janni W., John E.M., Dork T., Peterlongo P., Mannermaa A., Bolla M.K., Wang Q., Dennis J., Ahearn T., Andrulis I.L., Anton-Culver H., Arndt V., Aronson K.J., Augustinsson A., Freeman L.E.B., Beckmann M.W., Beeghly-Fadiel A., Behrens S., Bermisheva M., Blomqvist C., Bogdanova N.V., Bojesen S.E., Brauch H., Brenner H., Burwinkel B., Canzian F., Chan T.L., Chang-Claude J., Chanock S.J., Choi J.-Y., Christiansen H., Clarke C.L., Couch F.J., Czene K., Daly M.B., Dos-Santos-Silva I., Dwek M., Eccles D.M., Ekici A.B., Eriksson M., Evans D.G., Fasching P.A., Figueroa J., Flyger H., Fritschi L., Gabrielson M., Gago-Dominguez M., Gao C., Gapstur S.M., Garcia-Closas M., Garcia-Saenz J.A., Jung A., Giles G.G., Goldberg M.S., Goldgar D.E., Guenel P., Haeberle L., Haiman C.A., Hakansson N., Hall P., Hamann U., Hartman M., Hauke J., Hein A., Hillemanns P., Hogervorst F.B.L., Hooning M.J., Kapoor P.M., Khusnutdinova E., Kim S.-W., Kitahara C.M., Koutros S., Kraft P., and Kristensen V.N.

Abstract

Fanconi anemia (FA) is a genetically heterogeneous disorder with 22 disease-causing genes reported to date. In some FA genes, monoallelic mutations have been found to be associated with breast cancer risk, while the risk associations of others remain unknown. The gene for FA type C, FANCC, has been proposed as a breast cancer susceptibility gene based on epidemiological and sequencing studies. We used the Oncoarray project to genotype two truncating FANCC variants (p.R185X and p.R548X) in 64,760 breast cancer cases and 49,793 controls of European descent. FANCC mutations were observed in 25 cases (14 with p.R185X, 11 with p.R548X) and 26 controls (18 with p.R185X, 8 with p.R548X). There was no evidence of an association with the risk of breast cancer, neither overall (odds ratio 0.77, 95%CI 0.44-1.33, p=0.4) nor by histology, hormone receptor status, age or family history. We conclude that the breast cancer risk association of these two FANCC variants, if any, is much smaller than for BRCA1, BRCA2 or PALB2 mutations. If this applies to all truncating variants in FANCC it would suggest there are differences between FA genes in their roles on breast cancer risk and demonstrates the merit of large consortia for clarifying risk associations of rare variants.

Published
2020

49. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.

Author

Briceno I., Guenel P., Haiman C.A., Hakansson N., Hall P., Harrington P.A., Hart S.N., Hartman M., Hillemanns P., Hopper J.L., Hou M.-F., Hunter D.J., Huo D., Ito H., Iwasaki M., Jakimovska M., Jakubowska A., John E.M., Presneau N., Rack B., Rau-Murthy R., Rennert G., Rennert H.S., Rhenius V., Romero A., Ruebner M., Saloustros E., Schmutzler R.K., Schneeweiss A., Scott C., Shah M., Shen C.-Y., Shu X.-O., Simard J., Sohn C., Southey M.C., Spinelli J.J., Tamimi R.M., Tapper W.J., Teo S.H., Terry M.B., Torres D., Truong T., Untch M., Vachon C.M., van Asperen C.J., Wolk A., Yamaji T., Zheng W., Ziogas A., Ziv E., Torres-Mejia G., Dork T., Swerdlow A.J., Hamann U., Schmidt M.K., Dunning A.M., Pharoah P.D.P., Easton D.F., Hooning M.J., Martens J.W.M., Hollestelle A., Liu J., Prager-van der Smissen W.J.C., Collee J.M., Bolla M.K., Wang Q., Michailidou K., Dennis J., Ahearn T.U., Aittomaki K., Ambrosone C.B., Andrulis I.L., Anton-Culver H., Antonenkova N.N., Arndt V., Arnold N., Aronson K.J., Augustinsson A., Auvinen P., Becher H., Beckmann M.W., Behrens S., Bermisheva M., Bernstein L., Bogdanova N.V., Bogdanova-Markov N., Bojesen S.E., Brauch H., Brenner H., Brucker S.Y., Bruning T., Burwinkel B., Cai Q., Cai H., Campa D., Canzian F., Castelao J.E., Chang-Claude J., Chanock S.J., Choi J.-Y., Christiaens M., Clarke C.L., Couch F.J., Czene K., Daly M.B., Devilee P., Dos-Santos-Silva I., Dwek M., Eccles D.M., Eliassen A.H., Fasching P.A., Figueroa J., Flyger H., Fritschi L., Gago-Dominguez M., Gapstur S.M., Garcia-Closas M., Garcia-Saenz J.A., Gaudet M.M., Giles G.G., Goldberg M.S., Goldgar D.E., Kaaks R., Kang D., Keeman R., Khusnutdinova E., Kim S.-W., Kraft P., Kristensen V.N., Kurian A.W., Le Marchand L., Li J., Lindblom A., Lophatananon A., Luben R.N., Lubinski J., Mannermaa A., Manoochehri M., Manoukian S., Margolin S., Mariapun S., Matsuo K., Maurer T., Mavroudis D., Meindl A., Menon U., Milne R.L., Muir K., Mulligan A.M., Neuhausen S.L., Nevanlinna H., Offit K., Olopade O.I., Olson J.E., Olsson H., Orr N., Park S.K., Peterlongo P., Peto J., Plaseska-Karanfilska D., Briceno I., Guenel P., Haiman C.A., Hakansson N., Hall P., Harrington P.A., Hart S.N., Hartman M., Hillemanns P., Hopper J.L., Hou M.-F., Hunter D.J., Huo D., Ito H., Iwasaki M., Jakimovska M., Jakubowska A., John E.M., Presneau N., Rack B., Rau-Murthy R., Rennert G., Rennert H.S., Rhenius V., Romero A., Ruebner M., Saloustros E., Schmutzler R.K., Schneeweiss A., Scott C., Shah M., Shen C.-Y., Shu X.-O., Simard J., Sohn C., Southey M.C., Spinelli J.J., Tamimi R.M., Tapper W.J., Teo S.H., Terry M.B., Torres D., Truong T., Untch M., Vachon C.M., van Asperen C.J., Wolk A., Yamaji T., Zheng W., Ziogas A., Ziv E., Torres-Mejia G., Dork T., Swerdlow A.J., Hamann U., Schmidt M.K., Dunning A.M., Pharoah P.D.P., Easton D.F., Hooning M.J., Martens J.W.M., Hollestelle A., Liu J., Prager-van der Smissen W.J.C., Collee J.M., Bolla M.K., Wang Q., Michailidou K., Dennis J., Ahearn T.U., Aittomaki K., Ambrosone C.B., Andrulis I.L., Anton-Culver H., Antonenkova N.N., Arndt V., Arnold N., Aronson K.J., Augustinsson A., Auvinen P., Becher H., Beckmann M.W., Behrens S., Bermisheva M., Bernstein L., Bogdanova N.V., Bogdanova-Markov N., Bojesen S.E., Brauch H., Brenner H., Brucker S.Y., Bruning T., Burwinkel B., Cai Q., Cai H., Campa D., Canzian F., Castelao J.E., Chang-Claude J., Chanock S.J., Choi J.-Y., Christiaens M., Clarke C.L., Couch F.J., Czene K., Daly M.B., Devilee P., Dos-Santos-Silva I., Dwek M., Eccles D.M., Eliassen A.H., Fasching P.A., Figueroa J., Flyger H., Fritschi L., Gago-Dominguez M., Gapstur S.M., Garcia-Closas M., Garcia-Saenz J.A., Gaudet M.M., Giles G.G., Goldberg M.S., Goldgar D.E., Kaaks R., Kang D., Keeman R., Khusnutdinova E., Kim S.-W., Kraft P., Kristensen V.N., Kurian A.W., Le Marchand L., Li J., Lindblom A., Lophatananon A., Luben R.N., Lubinski J., Mannermaa A., Manoochehri M., Manoukian S., Margolin S., Mariapun S., Matsuo K., Maurer T., Mavroudis D., Meindl A., Menon U., Milne R.L., Muir K., Mulligan A.M., Neuhausen S.L., Nevanlinna H., Offit K., Olopade O.I., Olson J.E., Olsson H., Orr N., Park S.K., Peterlongo P., Peto J., and Plaseska-Karanfilska D.

Abstract

In breast cancer, high levels of homeobox protein Hox-B13 (HOXB13) have been associated with disease progression of ER-positive breast cancer patients and resistance to tamoxifen treatment. Since HOXB13 p.G84E is a prostate cancer risk allele, we evaluated the association between HOXB13 germline mutations and breast cancer risk in a previous study consisting of 3,270 familial non-BRCA1/2 breast cancer cases and 2,327 controls from the Netherlands. Although both recurrent HOXB13 mutations p.G84E and p.R217C were not associated with breast cancer risk, the risk estimation for p.R217C was not very precise. To provide more conclusive evidence regarding the role of HOXB13 in breast cancer susceptibility, we here evaluated the association between HOXB13 mutations and increased breast cancer risk within 81 studies of the international Breast Cancer Association Consortium containing 68,521 invasive breast cancer patients and 54,865 controls. Both HOXB13 p.G84E and p.R217C did not associate with the development of breast cancer in European women, neither in the overall analysis (OR=1.035, 95% CI=0.859-1.246, P=0.718 and OR=0.798, 95% CI=0.482-1.322, P=0.381 respectively), nor in specific high-risk subgroups or breast cancer subtypes. Thus, although involved in breast cancer progression, HOXB13 is not a material breast cancer susceptibility gene.

Published
2020

50. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk

Author

Liu, J. (Jingjing), Prager-van der Smissen, W.J.C. (Wendy), Collée, J.M. (J Margriet), Bolla, M.K. (Manjeet K.), Wang, Q. (Qin), Michailidou, K. (Kyriaki), Dennis, J. (Joe), Ahearn, T.U. (Thomas U.), Aittomäki, K. (Kristiina), Ambrosone, C.B. (Christine), Andrulis, I.L. (Irene L.), Anton-Culver, H. (Hoda), Antonenkova, N.N. (Natalia N.), Arndt, V. (Volker), Arnold, N. (Norbert), Aronson, K.J. (Kristan J.), Augustinsson, A. (Annelie), Auvinen, P. (Päivi), Becher, H. (Heiko), Beckmann, M.W. (Matthias), Behrens, T.W. (Timothy), Bermisheva, M. (Marina), Bernstein, L. (Leslie), Bogdanova, N.V. (Natalia V.), Bogdanova-Markov, N. (Nadja), Bojesen, S.E. (Stig), Brauch, H. (Hiltrud), Brenner, H. (Hermann), Briceno, I. (Ignacio), Brucker, S.Y. (Sara Y.), Brüning, T. (Thomas), Burwinkel, B. (Barbara), Cai, Q. (Qiuyin), Cai, H. (Hui), Campa, D. (Daniele), Canzian, F. (Federico), Castelao, J.E. (Jose ), Chang-Claude, J. (Jenny), Chanock, S.J. (Stephen), Choi, J.-Y. (J.), Christiaens, M. (Melissa), Clarke, C. (Christine), Couch, F.J. (Fergus), Czene, K. (Kamila), Daly, M.B. (Mary), Devilee, P. (Peter), Santos Silva, I. (Isabel) dos, Dwek, M. (Miriam), Eccles, D.M. (Diana M.), Eliassen, A.H. (A Heather), Fasching, P.A. (Peter), Figueroa, J.D. (Jonine), Flyger, H. (Henrik), Fritschi, L. (Lin), Gago-Dominguez, M. (Manuela), Gapstur, S.M. (Susan M.), García-Closas, M. (Montserrat), García-Sáenz, J.A. (José A), Gaudet, M.M. (Mia M.), Giles, G.G. (Graham G.), Goldberg, M.S. (Mark), Radice, P. (Paolo), Guénel, P. (Pascal), Haiman, C.A. (Christopher), Håkansson, N. (Niclas), Hall, P. (Per), Harrington, P.A. (Patricia A.), Hart, S.N. (Steven N.), Hartman, J.M. (Joost), Hillemanns, P. (Peter), Hopper, J.L. (John), Hou, M.-F. (Ming-Feng), Hunter, D.J. (David), Huo, D. (Dezheng), Ito, H. (Hidemi), Iwasaki, M. (Motoki), Jakimovska, M. (Milena), Jakubowska, A. (Anna), John, E.M. (Esther), Kaaks, R. (Rudolf), Kang, D. (Daehee), Keeman, R. (Renske), Khusnutdinova, E.K. (Elza), Kim, S.-W. (Sung-Won), Kraft, P. (Peter), Kristensen, V. (Vessela), Kurian, A.W. (Allison W.), Le Marchand, L. (Loic), Li, J. (Jingmei), Lindblom, A. (Annika), Lophatananon, A. (Artitaya), Luben, R.N. (Robert N.), Lubinski, J. (Jan), Mannermaa, A. (Arto), Manoochehri, M. (Mehdi), Manoukian, S. (Siranoush), Margolin, S. (Sara), Mariapun, S. (Shivaani), Matsuo, K. (Keitaro), Maurer, T. (Tabea), Mavroudis, D. (Dimitris), Meindl, A. (Alfons), Menon, U. (Usha), Milne, R.L. (Roger), Muir, K. (Kenneth), Mulligan, A.-M. (Anna-Marie), Floris, O.A.M., Nevanlinna, H. (Heli), Offit, K. (Kenneth), Olopade, O.I. (Olofunmilayo), Olson, J.E. (Janet), Olsson, H. (Håkan), Orr, N. (Nick), Park, S.K. (Sue K.), Peterlongo, P. (Paolo), Peto, J. (Julian), Plaseska-Karanfilska, D. (Dijana), Presneau, N. (Nadege), Rack, B. (Brigitte), Rau-Murthy, R. (Rohini), Rennert, G. (Gad), Rennert, H.S. (Hedy S.), Rhenius, V. (Valerie), Romero, A. (Atocha), Ruebner, M. (Matthias), Saloustros, E. (Emmanouil), Schmutzler, R.K. (Rita), Schneeweiss, A. (Andreas), Scott, C.G. (Christopher G.), Shah, M. (Mitul), Shen, C.-Y. (Chen-Yang), Shu, X.-O. (Xiao-Ou), Simard, J. (Jacques), Sohn, C. (Christof), Southey, M.C. (Melissa), Spinelli, J.J. (John J.), Tamimi, R. (Rulla), Tapper, W.J. (William J.), Teo, S.H. (Soo H.), Terry, M.B. (Mary Beth), Torres, D. (Diana), Truong, T. (Thérèse), Untch, M. (Michael), Vachon, C. (Celine), van Asperen, C.J. (Christi J.), Wolk, K. (Kerstin), Yamaji, T. (Taiki), Zheng, W. (Wei), Ziogas, A. (Argyrios), Ziv, E. (Elad), Torres-Mejía, G. (Gabriela), Dörk, T. (Thilo), Swerdlow, A.J. (Anthony ), Hamann, U. (Ute), Schmidt, M.K. (Marjanka), Dunning, A.M. (Alison M.), Pharoah, P.D.P. (Paul), Adamo, P. (Pio) d', Hooning, M.J. (Maartje J.), Martens, J.W.M. (John), Hollestelle, A. (Antoinette), Liu, J. (Jingjing), Prager-van der Smissen, W.J.C. (Wendy), Collée, J.M. (J Margriet), Bolla, M.K. (Manjeet K.), Wang, Q. (Qin), Michailidou, K. (Kyriaki), Dennis, J. (Joe), Ahearn, T.U. (Thomas U.), Aittomäki, K. (Kristiina), Ambrosone, C.B. (Christine), Andrulis, I.L. (Irene L.), Anton-Culver, H. (Hoda), Antonenkova, N.N. (Natalia N.), Arndt, V. (Volker), Arnold, N. (Norbert), Aronson, K.J. (Kristan J.), Augustinsson, A. (Annelie), Auvinen, P. (Päivi), Becher, H. (Heiko), Beckmann, M.W. (Matthias), Behrens, T.W. (Timothy), Bermisheva, M. (Marina), Bernstein, L. (Leslie), Bogdanova, N.V. (Natalia V.), Bogdanova-Markov, N. (Nadja), Bojesen, S.E. (Stig), Brauch, H. (Hiltrud), Brenner, H. (Hermann), Briceno, I. (Ignacio), Brucker, S.Y. (Sara Y.), Brüning, T. (Thomas), Burwinkel, B. (Barbara), Cai, Q. (Qiuyin), Cai, H. (Hui), Campa, D. (Daniele), Canzian, F. (Federico), Castelao, J.E. (Jose ), Chang-Claude, J. (Jenny), Chanock, S.J. (Stephen), Choi, J.-Y. (J.), Christiaens, M. (Melissa), Clarke, C. (Christine), Couch, F.J. (Fergus), Czene, K. (Kamila), Daly, M.B. (Mary), Devilee, P. (Peter), Santos Silva, I. (Isabel) dos, Dwek, M. (Miriam), Eccles, D.M. (Diana M.), Eliassen, A.H. (A Heather), Fasching, P.A. (Peter), Figueroa, J.D. (Jonine), Flyger, H. (Henrik), Fritschi, L. (Lin), Gago-Dominguez, M. (Manuela), Gapstur, S.M. (Susan M.), García-Closas, M. (Montserrat), García-Sáenz, J.A. (José A), Gaudet, M.M. (Mia M.), Giles, G.G. (Graham G.), Goldberg, M.S. (Mark), Radice, P. (Paolo), Guénel, P. (Pascal), Haiman, C.A. (Christopher), Håkansson, N. (Niclas), Hall, P. (Per), Harrington, P.A. (Patricia A.), Hart, S.N. (Steven N.), Hartman, J.M. (Joost), Hillemanns, P. (Peter), Hopper, J.L. (John), Hou, M.-F. (Ming-Feng), Hunter, D.J. (David), Huo, D. (Dezheng), Ito, H. (Hidemi), Iwasaki, M. (Motoki), Jakimovska, M. (Milena), Jakubowska, A. (Anna), John, E.M. (Esther), Kaaks, R. (Rudolf), Kang, D. (Daehee), Keeman, R. (Renske), Khusnutdinova, E.K. (Elza), Kim, S.-W. (Sung-Won), Kraft, P. (Peter), Kristensen, V. (Vessela), Kurian, A.W. (Allison W.), Le Marchand, L. (Loic), Li, J. (Jingmei), Lindblom, A. (Annika), Lophatananon, A. (Artitaya), Luben, R.N. (Robert N.), Lubinski, J. (Jan), Mannermaa, A. (Arto), Manoochehri, M. (Mehdi), Manoukian, S. (Siranoush), Margolin, S. (Sara), Mariapun, S. (Shivaani), Matsuo, K. (Keitaro), Maurer, T. (Tabea), Mavroudis, D. (Dimitris), Meindl, A. (Alfons), Menon, U. (Usha), Milne, R.L. (Roger), Muir, K. (Kenneth), Mulligan, A.-M. (Anna-Marie), Floris, O.A.M., Nevanlinna, H. (Heli), Offit, K. (Kenneth), Olopade, O.I. (Olofunmilayo), Olson, J.E. (Janet), Olsson, H. (Håkan), Orr, N. (Nick), Park, S.K. (Sue K.), Peterlongo, P. (Paolo), Peto, J. (Julian), Plaseska-Karanfilska, D. (Dijana), Presneau, N. (Nadege), Rack, B. (Brigitte), Rau-Murthy, R. (Rohini), Rennert, G. (Gad), Rennert, H.S. (Hedy S.), Rhenius, V. (Valerie), Romero, A. (Atocha), Ruebner, M. (Matthias), Saloustros, E. (Emmanouil), Schmutzler, R.K. (Rita), Schneeweiss, A. (Andreas), Scott, C.G. (Christopher G.), Shah, M. (Mitul), Shen, C.-Y. (Chen-Yang), Shu, X.-O. (Xiao-Ou), Simard, J. (Jacques), Sohn, C. (Christof), Southey, M.C. (Melissa), Spinelli, J.J. (John J.), Tamimi, R. (Rulla), Tapper, W.J. (William J.), Teo, S.H. (Soo H.), Terry, M.B. (Mary Beth), Torres, D. (Diana), Truong, T. (Thérèse), Untch, M. (Michael), Vachon, C. (Celine), van Asperen, C.J. (Christi J.), Wolk, K. (Kerstin), Yamaji, T. (Taiki), Zheng, W. (Wei), Ziogas, A. (Argyrios), Ziv, E. (Elad), Torres-Mejía, G. (Gabriela), Dörk, T. (Thilo), Swerdlow, A.J. (Anthony ), Hamann, U. (Ute), Schmidt, M.K. (Marjanka), Dunning, A.M. (Alison M.), Pharoah, P.D.P. (Paul), Adamo, P. (Pio) d', Hooning, M.J. (Maartje J.), Martens, J.W.M. (John), and Hollestelle, A. (Antoinette)

Abstract

In breast cancer, high levels of homeobox protein Hox-B13 (HOXB13) have been associated with disease progression of ER-positive breast cancer patients and resistance to tamoxifen treatment. Since HOXB13 p.G84E is a prostate cancer risk allele, we evaluated the association between HOXB13 germline mutations and breast cancer risk in a previous study consisting of 3,270 familial non-BRCA1/2 breast cancer cases and 2,327 controls from the Netherlands. Although both recurrent HOXB13 mutations p.G84E and p.R217C were not associated with breast cancer risk, the risk estimation for p.R217C was not very precise. To provide more conclusive evidence regarding the role of HOXB13 in breast cancer susceptibility, we here evaluated the association between HOXB13 mutations and increased breast cancer risk within 81 studies of the international Breast Cancer Association Consortium containing 68,521 invasive breast cancer patients and 54,865 controls. Both HOXB13 p.G84E and p.R217C did not associate with the development of breast cancer in European women, neither in the overall analysis (OR = 1.035, 95% CI = 0.859-1.246, P = 0.718 and OR = 0.798, 95% CI = 0.482-1.322, P = 0.381 respectively), nor in specific high-risk subgroups or breast cancer subtypes. Thus, although involved in breast cancer progression, HOXB13 is not a material breast cancer susceptibility gene.

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results